Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Patrangsit Healthcare Group PCL EV-to-EBITDA?
Patrangsit Healthcare Group PCLBKK:PHG +0.98%49 EV-to-EBITDA is 5.32 as of Sep. 17, 2026, which is 26% below its 10-year median of 7.15. GuruFocus rates BKK:PHG with a GF Score™ of 49/100 and a GF Value™ of ฿15.77 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 522 Healthcare Providers & Services companies, Patrangsit Healthcare Group PCL ranks better than 81.61% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Patrangsit Healthcare Group PCL's enterprise value is ฿2,109 Mil.
Patrangsit Healthcare Group PCL's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ฿397 Mil. Therefore, Patrangsit Healthcare Group PCL's EV-to-EBITDA for today is 5.32.
The historical rank and industry rank for Patrangsit Healthcare Group PCL's EV-to-EBITDA or its related term are showing as below:
BKK:PHG'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.93 Med: 7.15 Max: 16.52
Current: 5.32
During the past 5 years, the highest EV-to-EBITDA of Patrangsit Healthcare Group PCL was 16.52. The lowest was 3.93. And the median was 7.15.
BKK:PHG's EV-to-EBITDA is ranked better than 81.61% of 522
companies
in the Healthcare Providers & Services industry
Industry Median: 10.065
vs BKK:PHG: 5.32
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Patrangsit Healthcare Group PCL (BKK:PHG) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Patrangsit Healthcare Group PCL's PE Ratio (TTM) for today is calculated as:
Patrangsit Healthcare Group PCL's share price for today is ฿10.30.
Patrangsit Healthcare Group PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.782.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Patrangsit Healthcare Group PCL EV-to-EBITDA Chart
For the Medical Care Facilities subindustry, Patrangsit Healthcare Group PCL's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Patrangsit Healthcare Group PCL EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Patrangsit Healthcare Group PCL's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Patrangsit Healthcare Group PCL's EV-to-EBITDA falls into.
Patrangsit Healthcare Group PCL's current Enterprise Value is ฿2,109 Mil.
Patrangsit Healthcare Group PCL's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿397 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Patrangsit Healthcare Group PCL (BKK:PHG) has a EV-to-EBITDA of 5.32 as of Sep. 17, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Patrangsit Healthcare Group PCL. This is 26% below median its historical median of 7.15. Over the past decade, Patrangsit Healthcare Group PCL's EV-to-EBITDA has ranged from 3.93 to 16.52. According to the industry distribution chart, Patrangsit Healthcare Group PCL ranks #96 out of 522 companies in the Healthcare Providers & Services industry, placing it in the top 18.4%.
Is Patrangsit Healthcare Group PCL's EV-to-EBITDA too high?
Patrangsit Healthcare Group PCL's current EV-to-EBITDA of 5.32 is 26% below median its 10-year median of 7.15. Over the past 10 years, this metric has ranged from a low of 3.93 to a high of 16.52. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.07. Patrangsit Healthcare Group PCL's value of 5.32 is 47.1% below this industry median. Based on the distribution chart, Patrangsit Healthcare Group PCL ranks #96 out of 522 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Patrangsit Healthcare Group PCL has a GF Score™ of 49/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Patrangsit Healthcare Group PCL's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Patrangsit Healthcare Group PCL ranks #96 out of 522 companies for EV-to-EBITDA. This places Patrangsit Healthcare Group PCL in the top 18% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 10.07. Patrangsit Healthcare Group PCL's value of 5.32 is 47.1% below this benchmark. Historically, Patrangsit Healthcare Group PCL's own EV-to-EBITDA has ranged from 3.93 to 16.52 over the past decade. While the company's 10-year median is 7.15 vs. the industry median of 10.07, Patrangsit Healthcare Group PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.07, based on 522 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Patrangsit Healthcare Group PCL's current EV-to-EBITDA of 5.32 is 47.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Patrangsit Healthcare Group PCL. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Patrangsit Healthcare Group PCL's current EV-to-EBITDA is 5.32, which is 26% below median its own 10-year median of 7.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Patrangsit Healthcare Group PCL stock overvalued right now?
Based on GuruFocus' analysis, Patrangsit Healthcare Group PCL (BKK:PHG) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿15.77, compared to a current price of ฿10.30 — trading 34.7% below its estimated fair value. The current EV-to-EBITDA is 5.32, which is 26% below median its 10-year median of 7.15 and 47.1% below the Healthcare Providers & Services industry median of 10.07. Patrangsit Healthcare Group PCL's overall GF Score™ is 49/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Patrangsit Healthcare Group PCL (BKK:PHG), the current EV-to-EBITDA is 5.32 as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Patrangsit Healthcare Group PCL (BKK:PHG) Overvalued in 2026?
Based on GuruFocus' analysis, Patrangsit Healthcare Group PCL stock appears to be undervalued.
The current stock price of ฿10.30 is trading 34.7% below its estimated GF Value™ of ฿15.77.
GuruFocus considers Patrangsit Healthcare Group PCL to be Significantly Undervalued.
Key valuation signals for BKK:PHG:
EV-to-EBITDA: 5.32 (26% below median its 10-year median of 7.15)
GF Value™: ฿15.77 vs. price of ฿10.30 (34.7% below fair value)
Industry Position: 47.1% below the Healthcare Providers & Services median (#96 of 522)
No single metric tells the full story. See the BKK:PHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Patrangsit Healthcare Group PCL engages in the operations of the hospital business. The company's services include medical services, wardroom, health insurance customer services, corporate customer services and international services. It operates in one main reportable operating segment, which is hospital business and operates in one geographical area, which is Thailand.
49GF Score
Get the complete analysis for BKK:PHG
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:PHG has been successfully added to your 
